From January 1, 2024 to February 2, 2024, the company has repurchased 4,017,200 shares, representing 1.73% for CNY 38.41 million. With this, the company has completed the repurchase of 4,017,200 shares, representing 1.73% for CNY 38.41 million under the buyback announced on December 23, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.97 CNY | +1.35% | -1.89% | -3.93% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.93% | 376M | |
+9.85% | 72.5B | |
+11.69% | 9.11B | |
-12.85% | 5.07B | |
+60.16% | 5.01B | |
+1.60% | 3.85B | |
-19.20% | 2.46B | |
+18.65% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |
- Stock Market
- Equities
- 002873 Stock
- News Guiyang Xintian Pharmaceutical Co.,Ltd.
- Tranche Update on Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on December 23, 2023.